INITIAL INVESTMENT

2020

XenoTherapeutics is a clinical-stage, cell therapy company engineering personalized cells, tissues, and organs for transplantation.

STATUS

Active

HEADQUARTERS

Boston, MA

Other companies in the Dorilton Ventures portfolio